External Advisory Committee

The External Advisory Committee (EAC) consists of 7 key opinion leaders who provide an unbiased opinion on study performance and outcome, including decision making regarding project status and termination if interim analysis demonstrates no benefit of the trial agent.

Department of Internal Medicine & Division of Hematology

Comprehensive Cancer Center

Ohio State University

Professor

John C. Byrd, MD

Orthopedic Surgery

Duke Cancer Institute

Assistant Professor

Will C. Eward, DVM, MD

Screen Shot 2019-04-06 at 9.33.17 PM.png

Surgical Oncologist

Urologic Oncologist

Duke University

Associate Professor

Brant A. Inman, MD, MS

Screen Shot 2019-04-06 at 9.33.36 PM.png

Department of Molecular Medicine

Division of Hematology

Department of Internal Medicine

Mayo Clinic

Consultant / Professor

Steve J. Russell, MD, PhD

Center for Sarcoma & Bone Oncology

Dana-Farber Cancer Institute

Executive Director, Clinical & Translational Research

Ludwig Institute for Cancer Research

Professor/Director

George Demetri, MD

Screen Shot 2019-04-06 at 9.33.50 PM.png

Co-Director, Cancer Immunology Program, Yale Cancer Center

Co-Director, Yale SPORE in Skin Cancer

Professor

Mario Sznol, MD

Screen Shot 2019-04-06 at 9.33.27 PM.png

Pediatrics & Internal Medicine

Stanford University School of Medicine

Professor

External Advisory Committee

John C. Byrd, MD

Will C. Eward, DVM, MD

Brant A. Inman, MD, MS

Steve J. Russell, MD, PhD

George Demetri, MD

Mario Sznol, MD

Crystal Mackall, MD